Format

Send to

Choose Destination
Curr Rheumatol Rep. 2020 Jan 7;22(1):3. doi: 10.1007/s11926-019-0857-2.

Challenges in the Diagnosis and Treatment of Lyme Disease.

Author information

1
Section of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, 60 Temple Street, Suite 6A, New Haven, CT, 06510, USA. robert.schoen@yale.ed.

Abstract

PURPOSE OF REVIEW:

Since recognition in 1975, Lyme disease has become the most common vector-borne illness in North America and Europe. The clinical features are well-characterized and treatment is usually curative, but misperceptions about morbidity persist. The purpose of this review is to examine advances in the diagnosis and treatment of Lyme disease, as well as ongoing management challenges.

RECENT FINDINGS:

It is useful to recognize that Lyme disease occurs in stages, with early- and late-stage disease. Clinical expression is in part determined by Borrelial variability. For example, some strains of Borrelia burgdorferi, the causative organism in North America, are particularly arthritogenic. Most patients with early Lyme disease can be cured with a single course of oral antibiotic therapy, in contrast to some patients with Lyme arthritis, a late-stage manifestation, who are more antibiotic refractory and require other treatment strategies. Successful treatment of Lyme disease begins with successful diagnosis and with an understanding of the emergence, clinical features, and impact of Lyme disease over the past half century.

KEYWORDS:

Lyme arthritis; Lyme disease; Lyme disease treatment

PMID:
31912251
DOI:
10.1007/s11926-019-0857-2

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center